Free Trial

Vitalhub (TSE:VHI) Price Target Raised to C$14.00

Vitalhub logo with Medical background

Vitalhub (TSE:VHI - Free Report) had its price target upped by Raymond James Financial from C$13.50 to C$14.00 in a research report report published on Friday,BayStreet.CA reports. Raymond James Financial currently has an outperform rating on the stock. Raymond James Financial also issued estimates for Vitalhub's Q3 2025 earnings at $0.00 EPS, Q4 2025 earnings at $0.03 EPS and FY2025 earnings at $0.10 EPS.

Other research analysts have also issued reports about the company. National Bankshares set a C$14.00 price target on Vitalhub and gave the company an "outperform" rating in a report on Tuesday, June 10th. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. TD Securities boosted their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research report on Monday, March 31st. Finally, Scotiabank upped their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of C$13.25.

Check Out Our Latest Research Report on Vitalhub

Vitalhub Stock Down 1.0%

TSE VHI traded down C$0.11 on Friday, hitting C$11.04. The stock had a trading volume of 83,726 shares, compared to its average volume of 127,233. The company's 50-day moving average is C$10.60 and its two-hundred day moving average is C$10.61. Vitalhub has a one year low of C$6.74 and a one year high of C$12.34. The stock has a market cap of C$597.18 million, a price-to-earnings ratio of 179.56, a P/E/G ratio of 1.18 and a beta of 1.26.

Insiders Place Their Bets

In other Vitalhub news, Director Francis Nelson Shen bought 25,000 shares of the company's stock in a transaction dated Friday, May 16th. The shares were bought at an average price of C$10.23 per share, for a total transaction of C$255,750.00. Corporate insiders own 18.57% of the company's stock.

About Vitalhub

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Further Reading

Analyst Recommendations for Vitalhub (TSE:VHI)

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines